Overview
Catherine Guillemain-Metzler practices practicing medicine in Marseille, France.
Her clinical expertise encompasses Testicular Cancer and Infertility.
She is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Catherine Guillemain-Metzler
Is Catherine Guillemain-Metzler a top-rated expert for Testicular Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Catherine Guillemain-Metzler is classified as an Experienced expert for Testicular Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Catherine Guillemain-Metzler participate in research or clinical trials?
Yes. Catherine Guillemain-Metzler has published 37 articles and abstracts on conditions like Testicular Cancer. You can view a list of Catherine Guillemain-Metzler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- InfertilityMs. Guillemain-Metzler isExperienced. Learn about Infertility.
- Testicular CancerMs. Guillemain-Metzler isExperienced. Learn about Testicular Cancer.